MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer

BACKGROUND: Cancer cells exhibit an altered metabolism, which is characterized by a preference for aerobic glycolysis more than mitochondrial oxidation of pyruvate. Mitochondrial pyruvate carrier 1 (MPC1) and mitochondrial pyruvate carrier 2 (MPC2) play a bottleneck role by transporting pyruvate int...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Li, Xiaoli, Ji, Yasai, Han, Gaoyang, Li, Xiaoran, Fan, Zhirui, Li, Yaqing, Zhong, Yali, Cao, Jing, Zhao, Jing, Zhang, Mingzhi, Wen, Jianguo, Goscinski, Mariusz Adam, Nesland, Jahn M., Suo, Zhenhe
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5112705/
https://ncbi.nlm.nih.gov/pubmed/27852261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2941-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars